SCHEMBL4618111

SCHEMBL4618111

CC(C)(C)OC(=O)[C@@H](N)Cc1ccc(OC(=O)N2CCCC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.52
▸ NPC1 O15118 3/20 0.52
▸ MAPT P10636 3/20 0.52
▸ RAB9A P51151 3/20 0.52
▸ HTT P42858 2/20 0.52
▸ ALDH1A1 P00352 1/20 0.51
▸ POLB P06746 1/20 0.51
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ LMNA P02545 2/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ SRD5A1 P18405 2/20 0.43
▸ PTGS2 P35354 1/20 0.41
▸ ITGB1 P05556 1/20 0.40
▸ ITGA4 P13612 1/20 0.40
▸ ITGB7 P26010 1/20 0.40
▸ CACNA1B Q00975 2/20 0.39
▸ ATM Q13315 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2058594 0.91 ITGB1 (0.48) SMN1; SMN2NPC1MAPTRAB9AHTT
SCHEMBL8048237 0.91 ITGB1 (0.48) SMN1; SMN2NPC1MAPTRAB9AHTT
SCHEMBL13043085 0.88 RAB9A (0.39) SMN1; SMN2NPC1MAPTRAB9AHTT
SCHEMBL17822346 0.86 ALDH1A1 (0.55) SMN1; SMN2NPC1MAPTRAB9AHTT
SCHEMBL17822347 0.86 ALDH1A1 (0.55) SMN1; SMN2NPC1MAPTRAB9AHTT
SCHEMBL31524158 0.83 NPC1 (0.49) SMN1; SMN2NPC1MAPTRAB9AHTT
SCHEMBL2951695 0.82 ALDH1A1 (0.59) SMN1; SMN2NPC1MAPTRAB9AHTT
SCHEMBL5009929 0.81 ALDH1A1 (0.62) SMN1; SMN2NPC1MAPTRAB9AHTT
SCHEMBL5013682 0.80 ALDH1A1 (0.55) SMN1; SMN2NPC1MAPTRAB9AHTT
SCHEMBL3729750 0.78 ACACB (0.50) CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940827-A1 CARBAMATE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals Inc. (US) 2008-07-09 — — EP claimed
WO-2007041324-A1 CARBAMATE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 2007-04-12 — — WO claimed
EP-1940827-A1 CARBAMATE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals Inc. (US) 2008-07-09 — — EP disclosed
WO-2007041324-A1 CARBAMATE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 2007-04-12 — — WO disclosed
Send feedback